Lebwohl David

CIK 00018108821 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001810882

Recent Transactions

50 trades

Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−11,903→ 121,249 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-03-01+61,714→ 61,714 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+43,200→ 130,866 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-03$12.18/sh−9,557→ 87,666 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2025-01-01−3,189→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-01+3,189→ 97,223 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-03-01+55,855→ 55,855 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-01+38,701→ 93,073 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$29.46/sh−5,843→ 54,372 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-01+3,187→ 60,215 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2024-01-01−3,187→ 3,189 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-03-01+43,342→ 43,342 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+30,674→ 56,361 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-04$37.21/sh−2,574→ 25,687 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2023-01-01−3,187→ 6,376 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-01+3,187→ 28,261 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+13,816→ 13,816 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+20,203→ 20,203 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-03-01+13,816→ 24,738 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2022-01-01−3,187→ 9,563 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01+3,187→ 11,973 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01$112.24/sh−1,051→ 10,922 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-11-05$131.71/sh−1,200→ 9,914 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-11-05−2,400→ 180,077 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-11-05$132.62/sh−452→ 9,462 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-11-05$135.34/sh−200→ 8,714 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-11-05$134.07/sh−548→ 8,914 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-11-05$12.62/sh+2,400→ 11,114 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$127.81/sh−849→ 9,714 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$129.83/sh−525→ 8,964 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$12.62/sh+2,400→ 11,114 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$126.92/sh−551→ 10,563 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$129.01/sh−225→ 9,489 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-10-14$130.47/sh−250→ 8,714 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-10-14−2,400→ 182,477 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-09-24−7,923→ 184,877 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-24$12.62/sh+7,923→ 8,714 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-21$12.62/sh+2,400→ 3,191 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-21$149.81/sh−2,400→ 791 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-09-21−2,400→ 192,800 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$12.62/sh+2,400→ 3,191 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$160.10/sh−150→ 791 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$159.19/sh−1,100→ 941 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$156.70/sh−700→ 2,291 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−2,400→ 195,200 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$157.60/sh−250→ 2,041 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$155.43/sh−200→ 2,991 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-09−2,400→ 197,600 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-09$164.05/sh−2,400→ 791 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-09$12.62/sh+2,400→ 3,191 total

Companies

Intellia Therapeutics, Inc.
EVP, Chief Medical Officer
$NTLA

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov